BioSpace News Archive

New antagonists targeting misfolded RACK1 prevent dysfunctional protein aggregates from forming and restore normal function

LabCorp announced that members of the executive management team will participate in a virtual fireside chat at the Bank of America Securities 2020 Health Care Conference on Wednesday, May 13, at 10:20 a.m. ET.

TherapeuticsMD, Inc., an innovative, leading women’s healthcare Company, reported financial results for the first quarter ended March 31, 2020.

Amicus Therapeutics a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases announced the acceptance of several abstracts for presentation at the American Society of Gene & Cell Therapy 23rd Annual Meeting being held virtually on May 12 – 15.

Company will award approximately 20 grants totaling up to $100,000 to nonprofit community-based organizations that support sickle cell disease and beta-thalassemia patients and families

Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, announced that Ted White, Verrica President and CEO, will virtually present at two upcoming virtual healthcare conferences.

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, announced its first-quarter 2020 financial results.

Viela Bio announced it will host a webcast and conference call on Wednesday, May 13, 2020 at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights.

Announced 14 presentations at upcoming American Society of Gene and Cell Therapy (ASGCT) Virtual Annual Meeting highlighting Huntington’s disease, ALS SOD1, vectorized antibodies, novel capsids, and manufacturing

Microbix Biosystems Inc., an award-winning life sciences innovator and exporter, announces that it has begun providing its REDx™FLOQ® SARS-CoV-2 swab-format and REDx™ SARS-CoV-2 vial format quality assessment products as controls to clinical laboratories in Canada.